Scholars Central

Case reportPublished 26 Dec 2016

Bleomycin-Induced Flagellate Dermatitis

Authors: Partarrieu-Mejias F, Perez-Velasquez F, Alarcon-Cabrera R

Skin Diseases & Skin Care

Volume 1 · Issue 2 · Pages 12

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Flagellate dermatitis is an uncommon cutaneous drug reaction with a characteristic whip-like appearance that occurs in the setting of bleomycin administration, an agent used in chemotherapy. Bleomycin toxicity is frequently dose-related and lesions typically disappear after discontinuation of the drug although residual hyperpigmentation can remain. Due to the number of patients undergoing treatment with cytotoxic agents such as bleomycin, physicians should be able to recognize this entity once it occurs and determine its severity, in order to decide whether to continue or stop administrating the responsible drug. We present the case of a 43 year-old woman that developed an erythematous, linear and pruriginous skin rash 15 days after starting her first chemotherapy cycle for Hodgkin's disease.

Subjects

Dermatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Skin Diseases & Skin Care.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSkin Diseases & Skin Care
  • SubjectDermatology
  • BylineArticles whose byline prints “Partarrieu-Mejias F”
  • BylineArticles whose byline prints “Perez-Velasquez F”
  • BylineArticles whose byline prints “Alarcon-Cabrera R”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels